Showing results (31-40 of 86) with videos related to
Sort By:
Pageof 9
Ryumachi. [Rheumatism]|April 12, 2001
[Evaluation of cerebrovascular events in patients with rheumatoid arthritis]T Fujibayashi, Y Tamura, S Tsuboi, et al.Gene Therapy|December 24, 2004
Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/ablK Miyake, K Inokuchi, N Miyake, et al.Bulletin (Hospital for Joint Diseases (New York, N.Y.))|January 1, 1993
The treatment of intracapsular hip fractures with total hip arthroplasty in rheumatoid arthritisT Asai, I Nagaya, N Miyake, et al.Gene Therapy|February 28, 2014
Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vectorN Miyake, K Miyake, N Asakawa, et al.The Japanese Journal of Antibiotics|October 1, 1990
[Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus]K Saionji, M Shitara, N Miyake, et al.General Pharmacology|January 1, 1986
Selectivity of cerebral vasodilators on basilar arteriesI Takayanagi, K Koike, N Miyake, et al.The Japanese Journal of Antibiotics|February 1, 1992
[Free concentration and protein binding of ceftriaxone]K Saionji, N Miyake, K Miyake, et al.Nephron|November 10, 1998
Biochemical renal manifestations induced by consecutive administration of gentamicin in ratsA Soejima, S Ishizuka, M Suzuki, et al.The Biochemical Journal|December 15, 1991
Phosphorylation in vitro of the 85 kDa subunit of phosphatidylinositol 3-kinase and its possible activation by insulin receptor tyrosine kinaseH Hayashi, N Miyake, F Kanai, et al.Japanese Journal of Pharmacology|July 11, 2000
Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonistN Miyake, R Fujita, M Ishikawa, et al.Pageof 9